Position in ZLAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,692,658
+$2,500,165 QoQ
Shares Held
246,982
+111.9% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 92 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,299,463 across 137 Biotechnology names. ZLAB ranks #41 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in ZLAB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,692,658 | 246,982 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,192,493 | 116,560 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,160,958 | 65,814 | Shares | Defined | 2026-02-13 | |
| 2022-03-31 | $309,091 | 7,028 | Shares | Defined | 2022-05-12 | |
| 2020-12-31 | $68,223,810 | 504,092 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,963,657 | 83,728 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $6,885,697 | 83,839 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $2,225,223 | 43,225 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||